Overview

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate an ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis using the Conjunctival Allergen Challenge (CAC) model.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Olopatadine Hydrochloride
Ophthalmic Solutions
Pharmaceutical Solutions